{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:44:58Z","timestamp":1784853898063,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40120-025-00871-2","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T09:52:32Z","timestamp":1766656352000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Informant-Based Questionnaires in the Diagnostic Pathway for Screening of Cognitive Impairment"],"prefix":"10.1007","volume":"15","author":[{"given":"Abarajithan","family":"Chandrasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malek-Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Decourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan N.","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"issue":"24","key":"871_CR1","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules. 2020;25(24):5789.","journal-title":"Molecules"},{"issue":"3","key":"871_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"871_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87(5):539\u201347.","journal-title":"Neurology"},{"issue":"8","key":"871_CR4","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"871_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13670-018-0236-2","volume":"7","author":"JE Galvin","year":"2018","unstructured":"Galvin JE. Using informant and performance screening methods to detect mild cognitive impairment and dementia. Curr Geriatr Rep. 2018;7(1):19\u201325.","journal-title":"Curr Geriatr Rep"},{"issue":"11","key":"871_CR6","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1212\/01.wnl.0000247042.15547.eb","volume":"67","author":"JE Galvin","year":"2006","unstructured":"Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology. 2006;67(11):1942\u20138.","journal-title":"Neurology"},{"issue":"2","key":"871_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/gps.5436","volume":"36","author":"HC Huang","year":"2021","unstructured":"Huang HC, Tseng YM, Chen YC, Chen PY, Chiu HY. Diagnostic accuracy of the clinical dementia rating scale for detecting mild cognitive impairment and dementia: a bivariate meta-analysis. Int J Geriatr Psychiatry. 2021;36(2):239\u201351.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"871_CR8","first-page":"932","volume":"72","author":"M Mazerolle","year":"2017","unstructured":"Mazerolle M, Regner I, Barber SJ, et al. Negative aging stereotypes impair performance on brief cognitive tests used to screen for predementia. J Gerontol B Psychol Sci Soc Sci. 2017;72(6):932\u20136.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"2","key":"871_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/WAD.0000000000000008","volume":"28","author":"M Razavi","year":"2014","unstructured":"Razavi M, Tolea MI, Margrett J, et al. Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE. Alzheimer Dis Assoc Disord. 2014;28(2):156\u201361.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"871_CR10","doi-asserted-by":"publisher","first-page":"e0291291","DOI":"10.1371\/journal.pone.0291291","volume":"18","author":"R Tanwani","year":"2023","unstructured":"Tanwani R, Danquah MO, Butris N, et al. Diagnostic accuracy of Ascertain Dementia 8-item Questionnaire by participant and informant\u2014a systematic review and meta-analysis. PLoS ONE. 2023;18(9):e0291291.","journal-title":"PLoS ONE"},{"issue":"3","key":"871_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-2010-101185","volume":"22","author":"MN Sabbagh","year":"2010","unstructured":"Sabbagh MN, Malek-Ahmadi M, Kataria R, et al. The Alzheimer\u2019s questionnaire: a proof of concept study for a new informant-based dementia assessment. J Alzheimers Dis. 2010;22(3):1015\u201321.","journal-title":"J Alzheimers Dis"},{"issue":"19","key":"871_CR12","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1001\/archinte.160.19.2964","volume":"160","author":"VG Valcour","year":"2000","unstructured":"Valcour VG, Masaki KH, Curb JD, Blanchette PL. The detection of dementia in the primary care setting. Arch Intern Med. 2000;160(19):2964\u20138.","journal-title":"Arch Intern Med"},{"issue":"5","key":"871_CR13","volume":"1","author":"M Malek-Ahmadi","year":"2015","unstructured":"Malek-Ahmadi M, Sabbagh MN. Development and validation of the Alzheimer\u2019s Questionnaire (AQ). J Nat Sci. 2015;1(5):e104.","journal-title":"J Nat Sci"},{"issue":"1","key":"871_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40478-023-01576-z","volume":"11","author":"RS Nelson","year":"2023","unstructured":"Nelson RS, Abner EL, Jicha GA, et al. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort. Acta Neuropathol Commun. 2023;11(1):89.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"871_CR15","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s40520-022-02222-9","volume":"34","author":"I Mohebpour","year":"2022","unstructured":"Mohebpour I, Malek-Ahmadi M, Virden T 3rd, et al. Neuropathologic validation of the Alzheimer\u2019s Questionnaire. Aging Clin Exp Res. 2022;34(11):2905\u20139.","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"871_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/WAD.0b013e3182769731","volume":"28","author":"M Malek-Ahmadi","year":"2014","unstructured":"Malek-Ahmadi M, Davis K, Belden CM, Sabbagh MN. Comparative analysis of the Alzheimer questionnaire (AQ) with the CDR sum of boxes, MoCA, and MMSE. Alzheimer Dis Assoc Disord. 2014;28(3):296\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"871_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-142388","volume":"46","author":"K Budolfson","year":"2015","unstructured":"Budolfson K, Malek-Ahmadi M, Belden CM, et al. Neuropsychological correlates of the Alzheimer\u2019s Questionnaire. J Alzheimers Dis. 2015;46(2):389\u201397.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"871_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1017\/S0033291700005742","volume":"19","author":"AF Jorm","year":"1989","unstructured":"Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19(4):1015\u201322.","journal-title":"Psychol Med"},{"issue":"7","key":"871_CR19","first-page":"CD010772","volume":"7","author":"JK Burton","year":"2021","unstructured":"Burton JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting. Cochrane Database Syst Rev. 2021;7(7):CD010772.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"871_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000321697","volume":"30","author":"SA Sikkes","year":"2010","unstructured":"Sikkes SA, van den Berg MT, Knol DL, et al. How useful is the IQCODE for discriminating between Alzheimer\u2019s disease, mild cognitive impairment and subjective memory complaints? Dement Geriatr Cogn Disord. 2010;30(5):411\u20136.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7","key":"871_CR21","first-page":"CD010079","volume":"7","author":"TJ Quinn","year":"2021","unstructured":"Quinn TJ, Fearon P, Noel-Storr AH, Young C, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations. Cochrane Database Syst Rev. 2021;7(7):CD010079.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"871_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.dadm.2015.03.003","volume":"1","author":"JE Galvin","year":"2015","unstructured":"Galvin JE. The Quick Dementia Rating System (QDRS): a rapid dementia staging tool. Alzheimers Dement (Amst). 2015;1(2):249\u201359.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"871_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3233\/ADR-170004","volume":"1","author":"SE Berman","year":"2017","unstructured":"Berman SE, Koscik RL, Clark LR, et al. Use of the Quick Dementia Rating System (QDRS) as an initial screening measure in a longitudinal cohort at risk for Alzheimer\u2019s disease. J Alzheimers Dis Rep. 2017;1(1):9\u201313.","journal-title":"J Alzheimers Dis Rep"},{"issue":"3","key":"871_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000524548","volume":"51","author":"K Duff","year":"2022","unstructured":"Duff K, Wan L, Levine DA, et al. The Quick Dementia Rating System and its relationship to biomarkers of Alzheimer\u2019s disease and neuropsychological performance. Dement Geriatr Cogn Disord. 2022;51(3):214\u201320.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"871_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jgs.18151","volume":"71","author":"DS Powell","year":"2023","unstructured":"Powell DS, Reed NS, Oh E, Samus QM, Deal JA, Wolff JL. The role of care partners in medical visits of older adults with hearing loss and dementia: a national study. J Am Geriatr Soc. 2023;71(3):909\u201315.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"871_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1017\/S1041610209008941","volume":"21","author":"P Hancock","year":"2009","unstructured":"Hancock P, Larner AJ. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke\u2019s Cognitive Examination-Revised (ACE-R) in a memory clinic-based population. Int Psychogeriatr. 2009;21(3):526\u201330.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"871_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13643-020-01530-3","volume":"9","author":"M Taylor-Rowan","year":"2020","unstructured":"Taylor-Rowan M, Nafisi S, Patel A, Burton JK, Quinn TJ. Informant-based screening tools for diagnosis of dementia, an overview of systematic reviews of test accuracy studies protocol. Syst Rev. 2020;9(1):271.","journal-title":"Syst Rev"},{"issue":"5\u20136","key":"871_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000437092","volume":"40","author":"TK Phung","year":"2015","unstructured":"Phung TK, Chaaya M, Asmar K, et al. Performance of the 16-item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE) in an Arabic-speaking older population. Dement Geriatr Cogn Disord. 2015;40(5\u20136):276\u201389.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"871_CR29","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708-821.","DOI":"10.1002\/alz.13809"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00871-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00871-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00871-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:51:43Z","timestamp":1768398703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00871-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00871-2","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Abarajithan Chandrasekaran has nothing to disclose. Marwan N. Sabbagh discloses that he consults for Alzheon, Athira, Biogen, Roche-Genentech, Synaptogenix, Novo Nordisk, Signant Health, Prothena, Eisai, GSK, Abbvie, Lilly, and Neurotherapia. Marwan N. Sabbagh is an Editor-in-Chief of\n                      Neurology and Therapy\n                      . Marwan N. Sabbagh was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Boris Decourt is a consultant for Lighthouse Pharmaceuticals. Michael Malek-Ahmadi discloses that he consults for the Biomedical Research Alliance of New York","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}